Differential expression of insulin-like growth factor binding proteins in high versus low gleason score prostate cancer

Journal of Urology

Volumn 159, Issue 4, 1998, Pages 1379-1383

  Figueroa, Jose A ^a   De Raad, Shannon ^a   Tadlock, Laura ^a   Speights, V O ^a   Rinehart, John J ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Binding proteins; Expression; Growth factors; IGFs; Prognosis; Prostate cancer

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; PROTEIN INDUCTION; RNA SYNTHESIS;

EID: 0031897867     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63620-6     Document Type: Article

References (20)

1. Krywicki, R. F. and Yee, D.: The insulin-like growth factor family of ligands, receptors and binding proteins. Breast Cancer Res. Treat., 22: 7, 1992.
2. Kimura, G., Kasuya, J., Giannini, S., Honda, Y., Mohan, S., Kawachi, M. H., Akimoto, M. and Fujita-Yamagushi, Y.: Insulin-like growth factor system components in human prostatic cancer cell-lines: LNCaP, DU145, PC-3. Int. J. Urol., 3: 39, 1996.
3. Pietrzkowski, Z., Mulholland, G., Gomella, L., Jameson, B. A., Wernicke, D. and Baserga, R.: Inhibition of growth of prostatic cell lines by peptide analogues of insulin-like growth factors. Cancer Res., 33: 1102, 1993.
4. Figueroa, J. A., Lee, A. V., Jackson, J. G. and Yee, D.: Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor binding protein-1: evidence for an IGF-II autocrine growth loop. J. Clin. Endocrinol. Metab., 80: 3476, 1995.
5. Angelloz-Nicoud, P. and Binoux, M.: Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line. Endocrinology, 136: 5485, 1995.
6. Jarrard, D. F., Bussemakers, M. J. G., Bova, G. S. and Isaacs, W. B.: Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues. Clin. Cancer Res., 1: 1471, 1995.
7. Tennant, M. K., Thrasher, B., Twomey, T. A., Drivdahl R. H., Birnbaum, R. S. and Plymate, S.: Protein and messenger ribonucleic acid (mRNA) for the type I insulin-like growth factor (IGF) receptor is decreased and IGF-II increased in human prostate carcinoma compared to benign prostate epithelium. J. Clin. Endocrinol. Metab., 81: 3774, 1996.
8. Cohen, P., Peehl, D. M., Stamey, T. A., Wilson, K. F., Clemmons, D. R. and Rosenfeld, R. G.: Elevated levels of insulin-like growth factor binding protein-2 in serum of prostate cancer patients. J. Clin. Endocrinol. Metab., 76: 1031, 1993.
9. Kanety, H., Madjar, J., Dagan, Y., Levi, J., Papa, M. Z., Pariente, C., Goldwasser, B. and Karasick, A.: Serum insulin-like growth factor binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum specific antigen. J. Clin. Endocrinol. Metab., 77: 229, 1993.
10. Thrasher, J. B., Tennant, M. K., Twomey, P. A., Hansberry, K. L., Wettlauffer, J. N. and Plymate, S. R.: Immunohistochemical localization of insulin-like growth factor binding proteins 2 and 3 in prostate tissue: clinical correlation. J. Urol., 155: 999, 1996.
11. Tennant, M. K., Thrasher, J. B., Twomey, P. A., Birnbaum, R. S. and Plymate, S. R.: Insulin-like growth factor binding protein-2 and -3 expression in benign human prostate epithelium, prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. J. Clin. Endocrinol. Metab., 81: 411, 1996.
12. Tennant, M. K., Thrasher, J. B., Twomey, P. A., Birnbaum, R. S. and Plymate, S. R.: Insulin-like growth factor binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization. J. Clin. Endocrinol. Metab., 81: 3783, 1996.
13. Wheeler, T. M. and Lebovitz, R. M.: Fresh tissue harvest for research from prostatectomy specimens. Prostate, 25: 274, 1994.
14. Yee, D., Cullen, K. J., Paik, S., Perdue, J. F., Hampton, B., Schwartz, A., Lippman, M. E. and Rosen, N.: Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res., 48: 6691, 1988.
15. Figueroa, J. A., Jackson, J. G., McGuire, W. L., Krywicki, R. F. and Yee, D.: Expression of insulin-like growth factor binding proteins in human breast cancer tissues correlates with estrogen receptor status. J. Cell. Biochem., 52: 196, 1993.
16. Chomczynski, P. and Sacchi, N.: Single step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156, 1987.
17. Shimasaki, S. and Ling, N.: Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog. Growth Factor Res., 3: 243, 1991.
18. Fontana, J. A., Burrows-Mezu, A., Clemmons, D. R. and LeRoith, D.: Retinoid modulation of insulin-like growth factor binding proteins and inhibition of breast carcinoma proliferation. Endocrinology, 128: 1115, 1991.
19. Buckbinder, L., Talbot, R., Velazco-Miguel, S., Takenaka, I., Faha, B., Selzinger, B. R. and Kley, N.: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature, 377: 646, 1995.
20. Jones, J. I., Gockerman, A., Busby, W. H., Camacho-Hubner, C. and Clemmons, D. R.: Extracellular matrix contains insulin-like growth factor binding protein-5 potentiation of the effects of IGF-I. J. Cell Biol., 121: 679, 1993.